SynthesisCurrent oncology (Toronto, Ont.)2023
Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Pei-Fei Liao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.